Novartis Ag (NVSEF) Change in Acquisitions & Divestments (2009 - 2026)

Novartis Ag has disclosed Change in Acquisitions & Divestments across 9 years of filings, most recently posting -$3.0 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at -$3.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $143.0 million (down 83.56% YoY), and the FY2025 annual result was -$24.0 million, down 242.86% from the prior year.
• Change in Acquisitions & Divestments came in at -$3.0 million for Q1 2026 at Novartis Ag, up from -$14.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $647.0 million in Q2 2024 to a low of -$14.0 million in Q4 2025.
• The 5-year median for Change in Acquisitions & Divestments is $55.0 million (2023), against an average of $97.4 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 1276.6% in 2024 and sank 104.76% in 2025, its largest moves.
• Novartis Ag's Change in Acquisitions & Divestments stood at $12.0 million in 2022, then surged by 1125.0% to $147.0 million in 2023, then surged by 53.74% to $226.0 million in 2024, then slumped by 106.19% to -$14.0 million in 2025, then jumped by 78.57% to -$3.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at -$3.0 million (Q1 2026), -$14.0 million (Q4 2025), and $140.0 million (Q3 2025), per Business Quant data.